
ONC News
BeOne Medicines Ltd.
$369.71
+$18.23(+5.19%)
39
Overall
25
Value
36
Tech
57
Quality
Market Cap
$39.69B
Volume
212.11K
52W Range
$253.95 - $385.22
Target Price
$427.03
ONC news: the latest BeOne Medicines Ltd. headlines, press releases and market updates, newest first.
Latest ONC News
- Bernstein Keeps Their Buy Rating on Moncler S.p.A. (0QII)TipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
- Oncoclínicas Launches Independent Probe Into Prior Management’s DealsTipRanks Brazil Auto-Generated Newsdesk · Oct 14, 2026
- Oncolytics Biotech Updates GOBLET Gastrointestinal Cancer StudyTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- Oncolytics Biotech Extends Pelareorep Patent Protection Into Late 2040sTipRanks Canadian Auto-Generated Newsdesk · Oct 12, 2026
- Company Moves to Exit Venture Stake in Oncosem via Borsa İstanbul Share SaleTipRanks Turkey Auto-Generated Newsdesk · Oct 12, 2026
- Truist Financial Remains a Buy on BeOne Medicines (ONC)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- BeOne Medicines Advances BGB-43395 With New Drug Interaction Study UpdateTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Borsa Istanbul Activates Circuit Breaker in Oncosem SharesTipRanks Turkey Auto-Generated Newsdesk · Oct 7, 2026
- ONCOSEM Shares Enter Circuit Breaker as Exchange Pauses TradingTipRanks Turkey Auto-Generated Newsdesk · Oct 5, 2026
- ONCOSEM Wins Three-Year Chemotherapy Services Contract with Bezmialem University HospitalTipRanks Turkey Auto-Generated Newsdesk · Oct 5, 2026
- BeOne Medicines Advances Tacabrutideg With New Liver Function StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- BeOne Medicines Advances Sonrotoclax Safety Study in Patients With Severe Liver ImpairmentTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- Oncoclínicas to Hold New Board Election After Director ResignationTipRanks Brazil Auto-Generated Newsdesk · Oct 1, 2026
- Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and BeOne Medicines (ONC)TipRanks Newsroom · Oct 1, 2026
- Ownership Shifts Highlight Active Trading in İzmir Fırça and PeersTipRanks Turkey Auto-Generated Newsdesk · Sep 30, 2026
- Financière Moncey Publishes 2026 Half‑Year Financial ReportTipRanks European Auto-Generated Newsdesk · Sep 29, 2026
- BeOne Medicines Advances BGB-58067 Tablet Study, Sharpening Early-Stage Investor FocusTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 28, 2026
- Oncolytics Advances Pelareorep Trial, Gains FDA AlignmentTipRanks Auto-Generated Newsdesk · Sep 28, 2026
- ONCSM Shares Enter Call Auction After Circuit Breaker TriggeredTipRanks Turkey Auto-Generated Newsdesk · Sep 28, 2026
- Analysts Offer Insights on Healthcare Companies: Oncolytics Biotech (ONCY) and Spyre Therapeutics (SYRE)TipRanks Newsroom · Sep 27, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ONC | $369.71 | +5.2% | 212.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |